A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Clinical trial NCT06011954 · RECRUITING
Trial details
- NCT number
- NCT06011954
- Sponsor
- Astellas Pharma Korea, Inc.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-01
- Primary completion
- 2027-07-31
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.